Prof. Stefano Indraccolo

Stefano Indraccolo is an Experimental Oncologist at the Basic Experimental and Translational Oncology Unit of Istituto Oncologico Veneto (IRCCS), where he is leading a research group. He graduated in Medicine and specialized in Oncology at the University of Padova in 1994. During the early years of his career, he spent almost two years as a post-doc at the Institute of Molecular Virology, GSF-Forschungszentrum, Munich (nowadays Helmholtz Zentrum Munich). He is an active member of Società Italiana di Cancerologia (SIC) and the European Association of Cancer Research (EACR). He has been involved in several international and national projects as a Principal Investigator, and his research work is currently supported by the AIRC, among other sponsors. Currently, his interest is mainly focused on understanding the metabolic adaptations of tumors to anti-angiogenic therapy and the mechanisms involved in this phenomenon, with the long-term aim of identifying new metabolic drugs to improve the therapeutic efficacy of angiogenesis inhibitors in cancer.